A Study to Evaluate the Efficacy and Safety of Adjunctive Troriluzole in Obsessive-Compulsive Disorder

Clinical trial NCT04693351 · COMPLETED

Trial details

NCT number: NCT04693351
Sponsor: Biohaven Pharmaceuticals, Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Obsessive-Compulsive Disorder

Start date: 2021-01-29
Primary completion: 2025-04-29
Enrollment: 589

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.